Overview

Bluebird Bio, Inc. is a biotechnology company dedicated to developing gene therapies for severe genetic diseases and cancer. The company focuses on addressing rare genetic conditions, offering potentially transformative treatments for patients who have few other therapeutic options.

Therapeutic areas

Genetic DiseasesOncology

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to bluebird bio, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Verified Supplier Partner

Is this bluebird bio, Inc.? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.